Protein-based therapy shows promise against resistant leukemia
Tuesday, January 27, 2015 - 09:30
in Health & Medicine
The efficacy and safety of the new fusion protein has been demonstrated in mouse models of aggressive human leukemia using leukemia cells taken directly from patients with ALL. Resistance of leukemia cells to contemporary chemotherapy is one of the most formidable obstacles to treating acute lymphoblastic leukemia (ALL), the most common form of childhood cancer.